Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance

Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance - The Experience of a High-volume Italian University Hospital

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The goal of this observational, no-profit, spontaneous, retrospective, monocentric study is to compare surgical and oncologic outcomes in patients affected by gastric cancer before and after the institution of the Tumor Board, a multidisciplinary weekly case discussion. The main question it aims to answer is whether the Textbook Outcome (TO) and Textbook Oncological Outcome (TOO) of patients with non-early, non-metastatic gastric cancer undergoing surgical treatment with curative intent have improved before (from January 2018 to November 2019) and after (from December 2019 onwards) the establishment of the Multidisciplinary Tumor Board (MTB) at Fondazione Policlinico Gemelli (FPG).

Who May Be Eligible (Plain English)

Who May Qualify: - pathology-confirmed diagnosis of gastric adenocarcinoma - age 18 years or older - surgical candidates with curative intent Who Should NOT Join This Trial: - Endoscopic Mucosal Resection (EMR) or Endoscopic Submucosal Dissection (ESD) - previous EMR or ESD (salvage surgery) - histologies other than adenocarcinoma (no squamous cell carcinomas, GISTs, sarcomas, lymphomas, etc) - unsufficient staging (unclear clinical stage at diagnosis) - emergency presentation (obstrucetd, significantly bleeding, perforated gastric cancer) - synchronous tumors affecting survival - pregnant patients - age \<18years Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * pathology-confirmed diagnosis of gastric adenocarcinoma * age 18 years or older * surgical candidates with curative intent Exclusion Criteria: * Endoscopic Mucosal Resection (EMR) or Endoscopic Submucosal Dissection (ESD) * previous EMR or ESD (salvage surgery) * histologies other than adenocarcinoma (no squamous cell carcinomas, GISTs, sarcomas, lymphomas, etc) * unsufficient staging (unclear clinical stage at diagnosis) * emergency presentation (obstrucetd, significantly bleeding, perforated gastric cancer) * synchronous tumors affecting survival * pregnant patients * age \<18years

Treatments Being Tested

OTHER

Multidisciplinary Tumor Board

Institution of Multidisciplinary Tumor Board for Gastric Cancer at Fondazione Policlinico Gemelli in november 2019

Locations (1)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, IT, Italy